CUR FEATURED NEWS & ANALYSIS
MORE FROM OUR PARTNERS
-
Neuralstem Phase I Results Encourage Market, Stimulate Buying 22 May 2013 - Seeking Alpha
-
Neuralstem: Update On Phase I Trial Of Neural Stem Cells In ALS Is Enc... 21 May 2013 - Seeking Alpha
-
A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013 20 May 2013 - Seeking Alpha
-
SmithOnStocks Opines On Stocks: May 19th Edition 19 May 2013 - Seeking Alpha
-
Smaller Companies With Great Potential For Big Returns 16 May 2013 - Seeking Alpha
-
Neuralstem: Update On ALS Trial Could Be A Catalyst For The Stock 16 May 2013 - Seeking Alpha
-
Neuralstem Rounding Second With Phase II ALS Trial 16 May 2013 - Seeking Alpha
-
SmithOnStocks Opines On Recent Biotech News 13 May 2013 - Seeking Alpha
-
Neuralstem: Anticipating More Efficacy Data From ALS Trial And Update ... 07 May 2013 - Seeking Alpha
-
StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company 02 May 2013 - Seeking Alpha
PRESS RELEASES
-
Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presente... 20 May 2013 - PR Newswire
-
Neuralstem CEO, Richard Garr, To Present At Annual World Stem Cells An... 16 May 2013 - PR Newswire
-
Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I A... 13 May 2013 - PR Newswire
-
Neuralstem Reports First Quarter Financial Results And Provides Busine... 10 May 2013 - PR Newswire
-
Neuralstem ALS Trial Investigator And Patient On Sirius XM 08 May 2013 - PR Newswire
-
Research and Markets: Depression - Pipeline Review, H1 2013 Report Fea... 02 May 2013 - Business Wire
-
Research and Markets: Ischemic Stroke - Pipeline Review, H1 2013 Repor... 29 Apr 2013 - Business Wire
-
Neuralstem ALS Trial Data Presented At The American Association Of Neu... 29 Apr 2013 - PR Newswire
